BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bright F, Chan G, van Hummel A, Ittner LM, Ke YD. TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Int J Mol Sci 2021;22:7781. [PMID: 34360544 DOI: 10.3390/ijms22157781] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Mcgrath MS, Zhang R, Bracci PM, Azhir A, Forrest BD. Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS. Cells 2023;12:1031. [DOI: 10.3390/cells12071031] [Reference Citation Analysis]
2 Gautam M, Genç B, Helmold B, Ahrens A, Kuka J, Makrecka-Kuka M, Günay A, Koçak N, Aguilar-Wickings IR, Keefe D, Zheng G, Swaminathan S, Redmon M, Zariwala HA, Özdinler PH. SBT-272 improves TDP-43 pathology in ALS upper motor neurons by modulating mitochondrial integrity, motility, and function. Neurobiol Dis 2023;178:106022. [PMID: 36716828 DOI: 10.1016/j.nbd.2023.106022] [Reference Citation Analysis]
3 Bedlack R, Barkhaus PE, Barnes B, Beauchamp M, Bertorini T, Bromberg MB, Carter GT, Chaudry V, Cudkowicz M, Jackson C, Levitsky G, Lund I, McDermott C, Novella S, Olby N, Ostrow L, Pattee GL, Heiman-Patterson T, Ratner D, Salmon K, Steves S, Terrelonge M, Wicks P, Wills AM. ALSUntangled #63: ketogenic diets. Amyotroph Lateral Scler Frontotemporal Degener 2023;24:159-63. [PMID: 34645313 DOI: 10.1080/21678421.2021.1990346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gautam M, Genç B, Helmold B, Ahrens A, Kuka J, Makrecka-kuka M, Günay A, Koçak N, Aguilar-wickings IR, Keefe D, Zheng G, Swaminathan S, Redmon M, Zariwala HA, Özdinler PH. SBT-272 improves TDP-43 pathology in the ALS motor cortex by modulating mitochondrial integrity, motility, and function.. [DOI: 10.1101/2022.10.04.510854] [Reference Citation Analysis]
5 Tran N, Lee B. Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies. Front Cell Dev Biol 2022;10:931968. [DOI: 10.3389/fcell.2022.931968] [Reference Citation Analysis]
6 Ooi S, Patel SK, Eratne D, Kyndt C, Reidy N, Lewis C, Lee SC, Darby D, Brodtmann A. Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes. JAD 2022. [DOI: 10.3233/jad-220272] [Reference Citation Analysis]
7 Arendash G, Abulaban H, Steen S, Andel R, Wang Y, Bai Y, Baranowski R, Mcgarity J, Scritsmier L, Lin X, Shen N, Aljassabi A, Li Y, Cao C. Transcranial Electromagnetic Treatment Stops Alzheimer’s Disease Cognitive Decline over a 2½-Year Period: A Pilot Study. Medicines 2022;9:42. [DOI: 10.3390/medicines9080042] [Reference Citation Analysis]
8 Garg P, Semmler S, Baudouin C, Velde CV, Plotkin SS. Misfolding-Associated Exposure of Natively Buried Residues in Mutant SOD1 Facilitates Binding to TRAF6. J Mol Biol 2022;:167697. [PMID: 35753527 DOI: 10.1016/j.jmb.2022.167697] [Reference Citation Analysis]
9 Amor S, Nutma E, Marzin M, Puentes F. Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis. Clin Exp Immunol 2021;206:301-13. [PMID: 34510431 DOI: 10.1111/cei.13660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Mentis AA, Bougea AM, Chrousos GP. Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored? Aging Brain 2021;1:100024. [PMID: 36911507 DOI: 10.1016/j.nbas.2021.100024] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]